NUE
39
-4
MAS
52
-2
EFX
60
11
AN
50
-5
PHM
53
-4
ISRG
68
-3
IVZ
50
-5
MU
42
7
CCI
23
-2
MCHP
43
6
IR
55
-3
IPG
49
2
AVGO
88
27
HIG
51
3
NWL
62
-3
ACN
45
-4
QCOM
55
2
TJX
64
-4
JPM
59
-3
LEN
45
3
NUE
39
-4
MAS
52
-2
EFX
60
11
AN
50
-5
PHM
53
-4
ISRG
68
-3
IVZ
50
-5
MU
42
7
CCI
23
-2
MCHP
43
6
IR
55
-3
IPG
49
2
AVGO
88
27
HIG
51
3
NWL
62
-3
ACN
45
-4
QCOM
55
2
TJX
64
-4
JPM
59
-3
LEN
45
3
Financhill
Back

Larimar Therapeutics 10K Form

Sell
47

LRMR
Larimar Therapeutics

Last Price:
6.17
Seasonality Move:
30.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LRMR News And Ratings

See the #1 stock for the next 7 days that we like better than LRMR

LRMR Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-24.61M
Price / Cash Flow: 0
Annual Sales: $3.11
Price / Book: 1.97

Profitability

EPS (TTM): -1.14000
Net Income (TTM): $-64.77M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Larimar Therapeutics Earnings Forecast

Key Larimar Therapeutics Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 3 years.

Larimar Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: LRMR
CUSIP: 517125
Website: larimartx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LRMR Technical Analysis vs Fundamental Analysis

Sell
47
Larimar Therapeutics (LRMR) is a Sell

Is Larimar Therapeutics a Buy or a Sell?